About Bacchus Vascular
Bacchus Vascular is a company based in Santa Clara (United States) founded in 1999 was acquired by Covidien in March 2009.. Bacchus Vascular has raised $31.5 million across 2 funding rounds from investors including Warburg Pincus, Covidien and Kaiser Permanente Ventures. Bacchus Vascular operates in a competitive market with competitors including Tactile Medical, Intervene, enVVeno Medical, Sky Medical Technology and DeVoro Medical, among others.
- Headquarter Santa Clara, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$31.5 M (USD)
in 2 rounds
-
Latest Funding Round
$6.5 M (USD), Series E
Apr 17, 2007
-
Investors
Warburg Pincus
& 3 more
-
Employee Count
Employee Count
-
Acquired by
Covidien
(Mar 01, 2009)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Bacchus Vascular
Bacchus Vascular has successfully raised a total of $31.5M across 2 strategic funding rounds. The most recent funding activity was a Series E round of $6.5 million completed in April 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series E — $6.5M
-
First Round
First Round
(08 Jul 2003)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2007 | Amount | Series E - Bacchus Vascular | Valuation |
investors |
|
| Jul, 2003 | Amount | Series D - Bacchus Vascular | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Bacchus Vascular
Bacchus Vascular has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Warburg Pincus, Covidien and Kaiser Permanente Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multi-stage private equity investments are pursued across diverse sectors.
|
Founded Year | Domain | Location | |
|
Tech and Life Sciences focused corporate VC firm investing in the US
|
Founded Year | Domain | Location | |
|
Investments in early and late-stage US companies are made.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Bacchus Vascular
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Bacchus Vascular
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bacchus Vascular Comparisons
Competitors of Bacchus Vascular
Bacchus Vascular operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tactile Medical, Intervene, enVVeno Medical, Sky Medical Technology and DeVoro Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Home therapy devices for lymphedema and venous ulcers are provided.
|
|
| domain | founded_year | HQ Location |
Catheter-based therapy for chronic venous insufficiency is developed.
|
|
| domain | founded_year | HQ Location |
Developer of medical device for the the treatment of venous diseases
|
|
| domain | founded_year | HQ Location |
Electro-stimulation devices are manufactured for deep vein thrombosis treatment.
|
|
| domain | founded_year | HQ Location |
Medical devices for treating cardiac diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of a device for CLI and PAD patients to prevent amputation
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Bacchus Vascular
Frequently Asked Questions about Bacchus Vascular
When was Bacchus Vascular founded?
Bacchus Vascular was founded in 1999 and raised its 1st funding round 4 years after it was founded.
Where is Bacchus Vascular located?
Bacchus Vascular is headquartered in Santa Clara, United States. It is registered at Santa Clara, California, United States.
Is Bacchus Vascular a funded company?
Bacchus Vascular is a funded company, having raised a total of $31.5M across 2 funding rounds to date. The company's 1st funding round was a Series D of $25M, raised on Jul 08, 2003.
What does Bacchus Vascular do?
Bacchus Vascular was focused on medical devices for the treatment of occlusive vascular disease for interventional radiologists and vascular surgeons in the United States. Its product, the TRELLIS-8 Peripheral Infusion System is an isolated thrombolysis catheter that enables treatment of deep vein thrombosis and arterial occlusions by targeted delivery of clot-dissolving drugs. The company was founded in 1999 and is based in Santa Clara, California. It was acquired by Covidien in 2009 which in turn was acquired by Medtronic in 2015.
Who are the top competitors of Bacchus Vascular?
Bacchus Vascular's top competitors include Tactile Medical, Intervene and enVVeno Medical.
Who are Bacchus Vascular's investors?
Bacchus Vascular has 4 investors. Key investors include Warburg Pincus, Covidien, Kaiser Permanente Ventures, and The Vertical Group.